Literature DB >> 571200

Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy.

F J ten Cate, J Roelandt.   

Abstract

Congestive heart failure with dilated left ventricle developed in two patients with symptomatic hypertrophic obstructive cardiomyopathy. Both patients previously underwent cardiac surgery for relief of their outflow obstruction. Alterations in structure and function of the left ventricle during their episode of cardiac failure and thereafter were documented by echocardiography. The findings suggest that progression to left ventricular dilatation is a potential complication in patients with hypertrophic obstructive cardiomyopathy.

Entities:  

Mesh：

Year:  1979        PMID： 571200     DOI： 10.1016/0002-8703(79)90012-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  10 in total

1.  Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.

Authors:  K L Vikstrom; S M Factor; L A Leinwand
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

2.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

3.  Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy.

Authors:  N Fujino; M Shimizu; H Ino; K Okeie; M Yamaguchi; T Yasuda; H Kokado; H Mabuchi
Journal:  Clin Cardiol       Date:  2001-05       Impact factor: 2.882

4.  Hypertrophic cardiomyopathy simulating an infiltrative myocardial disease.

Authors:  A Frustaci; F Loperfido; F Pennestrì
Journal:  Br Heart J       Date:  1985-09

5.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

6.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

7.  Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy.

Authors:  L L Cregler
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

8.  Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy.

Authors:  C Seiler; R Jenni; G Vassalli; M Turina; O M Hess
Journal:  Br Heart J       Date:  1995-11

9.  Hypertrophic cardiomyopathy without asymmetric hypertrophy.

Authors:  T Koide; T Narita; S Sumino
Journal:  Br Heart J       Date:  1982-05

Review 10.  Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.

Authors:  Derk O Verschure; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2015-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.